$115,60
-$2,49(-2,10 %)
*Data last updated: 2026-07-11 06:40 (UTC+8)
As of 2026-07-11 06:40, Insmed Incorporated (INSM) is priced at $115,60, with a total market cap of $23,11B, a P/E ratio of -27,15, and a dividend yield of 0,00 %. Today, the stock price fluctuated between $112,79 and $119,20. The current price is 2,49 % above the day's low and 3,02 % below the day's high, with a trading volume of 3,34M. Over the past 52 weeks, INSM has traded between $92,25 to $166,88, and the current price is -30,72 % away from the 52-week high.
INSM Key Stats
Yesterday's Close$104,74
Market Cap$23,11B
Volumen3,34M
P/E Ratio-27,15
Dividend Yield (TTM)0,00 %
Diluted EPS (TTM)5,50
Net Income (FY)-$1,27B
Revenue (FY)$606,42M
Earnings Date2026-08-06
EPS Estimate0,75
Revenue Estimate$390,08M
Shares Outstanding220,64M
Beta (1Y)0.774
About INSM
Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
SectorHealthcare
IndustryBiotechnology
CEOWilliam H. Lewis
HeadquartersBridgewater,NJ,US
Official Websitehttps://www.insmed.com
Employees (FY)1,66K
Average Revenue (1Y)$364,43K
Net Income per Employee-$767,29K
Insmed Incorporated (INSM) FAQ
What's the stock price of Insmed Incorporated (INSM) today?
x
Insmed Incorporated (INSM) is currently trading at $115,60, with a 24h change of -2,10 %. The 52-week trading range is $92,25–$166,88.
What are the 52-week high and low prices for Insmed Incorporated (INSM)?
x
What is the price-to-earnings (P/E) ratio of Insmed Incorporated (INSM)? What does it indicate?
x
What is the market cap of Insmed Incorporated (INSM)?
x
What is the most recent quarterly earnings per share (EPS) for Insmed Incorporated (INSM)?
x
Should you buy or sell Insmed Incorporated (INSM) now?
x
What factors can affect the stock price of Insmed Incorporated (INSM)?
x
How to buy Insmed Incorporated (INSM) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.